Learning objectives
Upon completion of the activity, participants should be able to:
- Summarize new scientific advancements in the etiology and treatment of IgAN.
- Interpret the most recent evidence-based efficacy and safety data for new and emerging therapies for IgAN.
- Incorporate new data on optimal management into their everyday clinical practice.